Mary Madison, RN, RAC-CT, CDP
Clinical Consultant – Briggs Healthcare
The National Institutes of Health (NIH) has updated the Coronavirus Disease 2019 (COVID-19) Treatment Guidelines website as of February 24, 2022. Here’s what you’ll see on the landing page:
The What’s New in the Guidelines information is located here. It includes:
- Therapeutic Management of Hospitalized Adults With COVID-19
- Therapeutic Management of Hospitalized Pediatric Patients With Multisystem Inflammatory Syndrome in Children (MIS-C) (With Discussion on Multisystem Inflammatory Syndrome in Adults [MIS-A])
- Antiviral Drugs That Are Approved, Authorized, or Under Evaluation for the Treatment of COVID-19
- Ritonavir-Boosted Nirmatrelvir (Paxlovid)
- Remdesivir
- Molnupiravir
- Table 2f. Characteristics of Antiviral Agents
- Antithrombotic Therapy in Patients With COVID-19
BriggsNetNews 